Inventor
YOULE RICHARD J
US20 patents
⚠️ This page may combine multiple inventors who share the name “YOULE RICHARD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
18 patentsUS5955073ASep 21, 1999
Selective RNase cytotoxic reagents
US HEALTH47 citations94
US5840840ANov 24, 1998
Selective RNase cytotoxic reagents
US HEALTH52 citations94
US5792458AAug 11, 1998
Mutant diphtheria toxin conjugates
US HEALTH85 citations92
US5208021AMay 4, 1993
Method of preparing diphtheria immunotoxins
US HEALTH108 citations92
US4500637AFeb 19, 1985
Prevention of graft versus host disease following bone marrow transplantation
US HEALTH33 citations92
US4440747AApr 3, 1984
Monoclonal antibody-ricin hybrids as a treatment of murine graft-versus-host disease
US HEALTH27 citations92
US6737511B1May 18, 2004
Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US HEALTH33 citations89
US6197528B1Mar 6, 2001
Composition of immunotoxins and retinoids and use thereof
US HEALTH33 citations89
US5728383AMar 17, 1998
Treatment of tumors of the central nervous system with immunotoxins
US HEALTH34 citations89
US5352447AOct 4, 1994
Immunotoxins for treatment of intracranial lesions and as adjunct to chemotherapy
US HEALTH20 citations89
US6649393B1Nov 18, 2003
Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methods
US HEALTH19 citations86
US4520226AMay 28, 1985
Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates
US HEALTH23 citations82
US4520011AMay 28, 1985
Inactivating protein synthesis by incubating anti-Thy 1.1-ricin a chain monoclonal antibody hybrids with target protein cells
US HEALTH6 citations73
US5942230AAug 24, 1999
Composition of immunotoxins and retinoids and use thereof
US HEALTH11 citations70
US4397843AAug 9, 1983
Mannose-6-phosphate-low density protein reagent effective against hypercholesterolemia
US HEALTH5 citations60
US6780413B2Aug 24, 2004
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
US HEALTH5 citations54
US6696064B2Feb 24, 2004
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy
US HEALTH0 citations47
US6649392B1Nov 18, 2003
Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methods
US HEALTH0 citations46